Whole Nutrition.
Nothing Removed.

This hypothesis paper proposes that PL-DHA, by virtue of its bilayer-penetrating structure, could enhance innate immune clearance of enveloped viruses such as SARS-CoV-2. The mechanism centers on PL-DHA’s capacity to integrate into viral membranes, increase fluidity, and facilitate reactive oxygen species entry during immune respiratory bursts—potentially compromising viral RNA integrity. Epidemiological correlations between population DHA status and COVID-19 severity are presented alongside cautionary notes on the pro-oxidant risks of conventional extracted omega-3 oils. The hypothesis warrants experimental validation in both cell culture and clinical settings.

This white paper details the biochemical and process-based advantages of ZipZyme™ Omega over conventional fish or algal oils. The product’s whole-cell format preserves active DHA synthase enzymes and endogenous antioxidants, enabling both direct dietary DHA provision and endogenous synthesis from glucose. In contrast, extracted oils—particularly EPA-rich fish oils—are prone to rapid post-opening oxidation, potentially generating neurotoxic lipid peroxides. The analysis positions ZipZyme™ Omega as a stable, enzyme-active, and oxidation-resistant source of phospholipid DHA suitable for long-term nutritional strategies.

This literature review synthesizes current understanding of lipid peroxidation in long-chain omega-3 supplements, emphasizing susceptibility of EPA and DHA to oxidative degradation and the potential for harmful secondary oxidation products. Evidence from animal models links oxidized oils to inflammation, organ pathology, and carcinogenesis, while human trial interpretations are confounded by a lack of reported oxidative indices (peroxide value, anisidine value, TOTOX). The review advocates for mandatory oxidative status reporting in clinical research to clarify efficacy and safety outcomes in omega-3 supplementation.

A controlled aquaculture trial at USDA ARS NCWMAC examined DHA accretion in juvenile Atlantic salmon fed ZipZyme™ Omega and ZipZyme™ Krumble at 5% dietary inclusion for two months, followed by a two-month washout. Both supplemented groups exhibited sustained DHA elevation relative to controls, with the ZipZyme™ Krumble group achieving a 34% net DHA increase despite cessation of supplementation. Given that preformed DHA in the feed could not account for the magnitude of tissue enrichment, results strongly support in vivo DHA biosynthesis via active algal DHA synthase enzymes. Expanded replication and isotopic tracer studies are warranted.

A 2020 on-farm feeding trial assessed the capacity of SmartZYME™ (precursor to ZipZyme™ Omega) to elevate DHA concentrations in chicken eggs. Two multi-week feeding periods revealed complex dynamics: limited short-term DHA transfer, potential preferential utilization of phospholipid DHA for systemic functions over yolk deposition, and post-supplementation persistence of elevated yolk DHA—suggestive of hepatic enzyme retention. Calculated DHA transfer efficiencies surpassed those reported for non-enzymatic algal TG-DHA feeds, supporting enzymatic synthesis pathways from non-HUFA precursors. Further structured, large-scale trials are recommended to validate these findings.

This peer-reviewed analysis explores the paradoxical role of DHA in neural tissue—structurally predisposed to oxidation due to high unsaturation yet frequently demonstrating neuroprotective effects. Mechanistic pathways are proposed wherein DHA, particularly when esterified in plasmalogens, functions as both a radical sink and membrane stabilizer. Data from in vivo and in vitro studies suggest enhanced antioxidant enzyme activity and altered lipid membrane packing as possible bases for reduced lipid peroxidation in DHA-enriched brains. Implications are discussed for DHA’s dual pro-oxidant/antioxidant capacity and its integration into targeted nutritional or therapeutic strategies for neuroprotection.

This comparative review evaluates the compositional and functional advantages of ZipZyme™ whole-cell DHA over extracted omega-3 oils. Key differentiators include the presence of active DHA synthase enzymes, which facilitate in situ conversion of short-chain carbon molecules directly to DHA without reliance on ALA precursors, and a high proportion of phospholipid-bound DHA, enhancing membrane incorporation efficiency. Oxidation stability testing demonstrated peroxide values as low as 0.1 meq/kg—well below the 5.0 meq/kg industry threshold—attributed to inherent antioxidant enzymes within the algal matrix. The findings underscore potential for superior bioavailability and reduced pro-oxidant risk compared to triglyceride-based fish or algal oils.

This technical overview synthesizes animal nutrition research on omega-3 fatty acids, with emphasis on the unique value proposition of ZipZyme™ Omega for companion animals. Unlike extracted oils, ZipZyme™ retains enzymatic activity capable of synthesizing DHA in vivo, potentially reducing saturated fat accumulation by converting glucose to DHA-rich lipids. Literature cited spans cardiovascular, dermatological, reproductive, and metabolic benefits in multiple species. The report positions ZipZyme™ as both a direct DHA source and a metabolic modulator, offering benefits beyond those achievable through oxidatively unstable, enzyme-deficient oil supplements.